Progress in Cardiovascular Diseases

Official account for Progress in Cardiovascular Diseases Journal. Impact Factor 7.6 #22/230 CV Journals. @ElsevierConnect

[Progress in Cardiovascular Diseases @PCVDJournal]

🆕📝 Coronary artery Ectatic/Aneurysmatic disease: From pathophysiology to management

🔗 https://t.co/VCG8VVAZfI

@GeorgeMM_GR @MavrogeniSophie

@Sciencedirect @ElsevierConnect

#Cardiology #cardioX #cardioTwitter

[Progress in Cardiovascular Diseases @PCVDJournal]

🆕📝 Effect of physical exercise-based cardiac rehabilitation on frail patients with heart failure: focus on endothelial dysfunction

🔗 https://t.co/NaB45Wp0Rm

@Sciencedirect @ElsevierConnect

#CardioX #Cardiology #CardioTwitter #CardioEd

[Progress in Cardiovascular Diseases @PCVDJournal]

🆕✍️ IGF-1 and vitamin D: Risk biomarkers or causal mediators of recovery after acute MI?

🔗 https://t.co/xjkI1tglkZ

@SumeetKhetarpal @AbbateAntonio

Original 📜

🔗 https://t.co/P3f2CuN2kq

@Sciencedirect @ElsevierConnect

#Cardiology #cardioX #CVprevention
#cardioTwitter

[Progress in Cardiovascular Diseases @PCVDJournal]

🆕✍️ Refining sudden cardiac death risk in hypertrophic cardiomyopathy: The interplay between atrial and ventricular arrhythmias

Editorial
🔗 https://t.co/sHYWisRx0j

@RaderFlorian

Article
🔗 https://t.co/nqu299Oq70

@Sciencedirect @ElsevierConnect

#Cardiology #CardioX

[Progress in Cardiovascular Diseases @PCVDJournal]

🚨🆕📝 The impact of Corona virus disease - 2019 on coronary atherosclerosis: Rationale and design of the COrona VIrus Disease-2019 computed tomography (COVID-CT) registry

🔗 https://t.co/wFpqEZ7ibf

@ArthurShiyovich @lesleejshaw

@ElsevierConnect

#Cardiology #CardioX

[Progress in Cardiovascular Diseases @PCVDJournal]

🚨🆕📝 Lipoprotein(a), remnant cholesterol, and high-sensitivity C-reactive protein as complementary biomarkers for myocardial infarction risk assessment

🔗 https://t.co/zQokQdz8Kg

@Kazibwe_md @DrMichaelShapir

@Sciencedirect @ElsevierConnect

#CardioTwitter #Cardiology

[Progress in Cardiovascular Diseases @PCVDJournal]

🆕 Editorial ⏬✍️

Papillary muscle LGE for sudden cardiac death risk stratification: Another brick beyond the wall — But can we see it clearly?

🔗 https://t.co/aOVXt8Tzhv

@Figliozzis @diegopenela1

@Sciencedirect @ElsevierConnect

#Cardiology #cardioTwitter #cardioX

[Progress in Cardiovascular Diseases @PCVDJournal]

🆕CarDiac magnEtic resonance for prophylactic implantable cardioVerter defibrillAtor ThErapy in ischemic dilated CardioMyopathy: Prognostic implication of papillary muscles involvement

🔗 https://t.co/pL3biKs9eU

@GiuseppeMuscog @gpontone1

#cardioX #cardioTwitter #cardiology

[Progress in Cardiovascular Diseases @PCVDJournal]

🆕CarDiac magnEtic resonance for prophylactic implantable cardioVerter defibrillAtor ThErapy in ischemic dilated CardioMyopathy: Prognostic implication of papillary muscles involvement

🔗 https://t.co/pL3biKs9eU

@GiuseppeMuscog @gpontone1

#cardioX #cardioTwitter #cardiology

[Progress in Cardiovascular Diseases @PCVDJournal]

📝🆕 Advanced CCTA imaging, angiography-based Radial Wall strain and μFR versus IVUS-NIRS to enhance identification of lipid-rich vulnerable plaques: A multimodality imaging approach

🔗 https://t.co/gcZq74YlvT

@GPontone1973 @gpontone1

#cardiotwitter #cardioX #cardiology

[Progress in Cardiovascular Diseases @PCVDJournal]

🆕📝 Obstructive sleep apnea and cardiac arrest in hypertrophic cardiomyopathy: An analysis of the nationwide inpatient sample database

🔗 https://t.co/O5hPbUCHW1

@Maisha12345 @AbdelazizMD1 @DrVikyath @danilorenzatti @aschenonegiugni

@Sciencedirect

#cardioX #Cardiology

[Progress in Cardiovascular Diseases @PCVDJournal]

🆕📝 Charting individualized pathways: IGF-1 and vitamin D in guiding personalized medicine for residual risk after AMI

🔗 https://t.co/Lvx0wHV8Oe

@AAaleksova

@Sciencedirect @ElsevierConnect

#cardioX #cardiotwitter #Cardiology
#CardioX

[Progress in Cardiovascular Diseases @PCVDJournal]

🆕✍️ Beyond the treadmill: The evolving role of coronary CTA in perioperative risk stratification

🔗 https://t.co/2r2Ocd3yRC

@OmarChehab1 @armin_zadeh

Original 📜

🔗 https://t.co/sBc5jKxgsZ

#Cardiology #CardioX #cardiovascular

@Sciencedirect @ElsevierConnect

[Progress in Cardiovascular Diseases @PCVDJournal]

🆕📝 Digital care in your pocket: The role of technology in exercise, fitness, prevention, and rehabilitation

🔗 https://t.co/CsNSyik1Gq

@patrickjdunn_ @UWisloff

@Sciencedirect @ElsevierConnect

#cardioX #cardiotwitter #cardiology #CardioX #CVprevention

[Progress in Cardiovascular Diseases @PCVDJournal]

Frailty should not be a barrier to recovery after valve intervention..it should be a target 🎯

🆕📝 Prehabilitation in frail patients undergoing cardiac valve intervention

🔗 https://t.co/YXASwKBdD9

@DFCapodanno

@Sciencedirect @ElsevierConnect

#cardiology #cardioX

[Progress in Cardiovascular Diseases @PCVDJournal]

🆕📝 Revascularization of patients with chronic total occlusion and left ventricular systolic dysfunction

🔗 https://t.co/jXxMynTRJl

@GiuseppeVadal3 @alfredorgalassi

@Sciencedirect @ElsevierConnect

#cardiology #cardioX #cardiotwitter

[Progress in Cardiovascular Diseases @PCVDJournal]

🆕✍️ Big data, blunt tools: What national registries still miss in aortic dissection

🔗 https://t.co/RqMVUx2xw5

@L_M_Obel @JesLindholt

@Sciencedirect @ElsevierConnect

#cardiology #cardioTwitter #cardioX #Cardiology

[Progress in Cardiovascular Diseases @PCVDJournal]

🆕✍️ Beyond body weight and BMI: Shifting the focus to excessive, ectopic, and dysfunctional adiposity

🔗 https://t.co/zw7swtUlG4

@dresalmeri @almucastro01

@ElsevierConnect

#cardiology #cardioX #cardiotwitter #Cardiology #CardioX

[Progress in Cardiovascular Diseases @PCVDJournal]

🆕📝 Wearable-derived REM sleep as a modifiable risk factor for cardiovascular disease: A multimodal prediction model in the All of Us Research Program

🔗 https://t.co/3erGO5LWbZ

@Jiseung_Kang

@ElsevierConnect @Scopus

#Cardiology #CardioX #cardiotwitter

[Progress in Cardiovascular Diseases @PCVDJournal]

✍️ Improving outcomes in severe mitral regurgitation due to annular calcification

🔗 https://t.co/ivBAd4YTPX

@GPress16

Original 📝⬇️

🔗 https://t.co/sbyaMmLSWS

@ElsevierConnect

#CardioX #Cardiology #cardiotwitter

[Progress in Cardiovascular Diseases @PCVDJournal]

Editor’s corner ✍️

Moving beyond what the eye can see: Subclinical disease, comprehensive diagnosis, and emerging therapeutics

🔗https://t.co/T9cJPD8i7l

@CardioMDPhD

@ElsevierConnect @Sciencedirect

#cardiotwitter #cardioX #cardiology